© Springer Nature Switzerland AG 2021
C. S. Foster et al. (eds.)Uveitishttps://doi.org/10.1007/978-3-030-52974-1_21

21. Acute Retinal Pigment Epitheliitis

Albert T. Vitale1   and Christopher D. Conrady2
(1)
Department of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, UT, USA
(2)
University of Michigan, Kellogg Eye Center – Ophthalmology and Visual Sciences, Ann Arbor, MI, USA
 
 
Albert T. Vitale
Keywords
Acute retinal pigment epitheliitisUveitis

Overview

  • Definition:
    • Rare, idiopathic, self-limited inflammatory condition of the outer retina and retinal pigment epithelium of unknown etiology

    • Also known as Krill’s disease

  • Symptoms:
    • Painless loss of vision
      • Acuity 20/20 to 20/100

    • Central scotoma, seen on Amsler grid testing

    • Metamorphopsia

  • Laterality
    • Unilateral or bilateral

  • Course
    • Acute onset of symptoms (days) with resolution over the next few months

  • Age of onset
    • 20s to 50s

  • Gender/race
    • No gender or racial predilection.

    • 2/3rds of case reports described in male patients.

  • Systemic association:
    • Flu-like prodrome 1–2 weeks prior

    • No other systemic association

Exam: Ocular

Anterior Segment

  • No signs of inflammation

Posterior Segment

  • Fine hyperpigmented stippling of the RPE within the macula surrounded by a hypopigmented halo

Exam: Systemic

  • Flu-like prodrome

Imaging

  • OCT : Dome-shaped hyperreflective lesion of the photoreceptors and outer retina with disruption of ellipsoid (EZ) and interdigitation (IZ) zones; upward displacement of the external limiting membrane (ELM); lesions normalize with disease resolution starting with ELM, then EZ, then IZ

  • FAF: slight increase in hyperfluorescence within the fovea and the areas corresponding to whitish dots (acute lesions) seen on examination

  • FA: transmission window defects within lesion without leakage with central blocking lesions corresponding to hyperpigmentation

  • ICG: mid-to-late phase hyperfluorescence of the lesion

  • VF: decreased threshold sensitivity within central field

  • mfERG: depressed central amplitudes

Laboratory and Radiographic Testing

  • No contributory testing

Differential Diagnosis

  • Multiple evanescent white dot syndrome (MEWDS)

  • Acute macular neuroretinopathy (AMN)

  • Unilateral acute idiopathic maculopathy (UAIM)

  • Solar retinopathy

Treatment

  • No treatment necessary, self-limited

  • Visual acuity returns to baseline within 2 months in 89%

  • Notably, oral steroids have been shown to slow recovery

Referral/Comanagement

  • None